111 related articles for article (PubMed ID: 37772545)
1. A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study.
Sawabata N; Morita K; Tatsumi S; Fujii T; Nishikawa T; Kawaguchi T; Arakane T; Tominaga Y; Sakaguchi H; Kobayashi T; Hontsu S; Yamamoto Y; Fujioka N; Ouji-Sageshima N; Ito T; Ohbayashi C
Anticancer Res; 2023 Oct; 43(10):4683-4690. PubMed ID: 37772545
[TBL] [Abstract][Full Text] [Related]
2. Cluster circulating tumor cells in surgical cases of lung cancer.
Sawabata N; Susaki Y; Nakamura T; Kawaguchi T; Yasukawa M; Taniguchi S
Gen Thorac Cardiovasc Surg; 2020 Sep; 68(9):975-983. PubMed ID: 32043230
[TBL] [Abstract][Full Text] [Related]
3. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
Bian J; Yan K; Liu N; Xu X
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2621-2630. PubMed ID: 32661602
[TBL] [Abstract][Full Text] [Related]
4. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
5. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
6. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
8. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
10. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
11. Verification of A New Filter for Isolation of Circulating Tumor Cells by Only Blood Filtration.
Morita K; Sawabata N; Tatsumi S; Fujii T; Nishikawa T; Kawaguchi T; Arakane T; Tominaga Y; Sakaguchi H; Kobayashi T; Hontsu S; Yamamoto Y; Fujioka N; Ouji-Sageshima N; Ito T; Ohbayashi C
Anticancer Res; 2022 Sep; 42(9):4305-4310. PubMed ID: 36039435
[TBL] [Abstract][Full Text] [Related]
12. High‑throughput and continuous flow isolation of rare circulating tumor cells and clusters in gastric cancer from human whole blood samples using electromagnetic vibration‑based filtration.
Xiang A; Xue M; Ren F; Wang L; Ye Z; Li D; Ji Q; Ji G; Lu Z
Oncol Rep; 2020 Jun; 43(6):1975-1985. PubMed ID: 32236590
[TBL] [Abstract][Full Text] [Related]
13. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
Bobek V; Gurlich R; Eliasova P; Kolostova K
World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
[TBL] [Abstract][Full Text] [Related]
16. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
18. Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
Yagi S; Koh Y; Akamatsu H; Kanai K; Hayata A; Tokudome N; Akamatsu K; Endo K; Nakamura S; Higuchi M; Kanbara H; Nakanishi M; Ueda H; Yamamoto N
PLoS One; 2017; 12(6):e0179744. PubMed ID: 28640869
[TBL] [Abstract][Full Text] [Related]
19. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.
Wang Y; Liu Y; Zhang Z; Lu B; Gao Y; Tong L; Hu M; Lin PP; Li B; Zhang T
BMC Cancer; 2023 Jun; 23(1):578. PubMed ID: 37349714
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
